News
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the ...
Within the family program agenda, Aardvark's Chief Medical Officer, Manasi Jaiman, M.D., will join a panel of clinicians to discuss the details of the company's ongoing Phase 3 HERO study.
Arkay Beverages, the pioneer in zero-proof spirits, is proud to announce that its entire range — including whisky, vodka, rum ...
Scientists have found a way to use the bacteria E.Coli to convert plastic waste into a popular painkiller, a study said ...
From the Scuola Superiore di Studi e di Perfezionamento “S. Anna” (T.S.), Pisa; Department of Reproductive Medicine and Child Development (T.S., A.R.G.) and Cellular and Developmental Biology Division ...
We present a combined experimental and theoretical study of the electronic transport through single-molecule junctions based on nitrile-terminated biphenyl derivatives. Using a scanning tunneling ...
Phase 2a data on Skye Bioscience's (NASDAQ:SKYE) cannabinoid-1 receptor blocker (CB1) for obesity, nimacimab, should be ...
Geneva, Switzerland, June 19, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company ...
SandboxAQ releases over 5 million AI-generated protein-drug structures to accelerate drug discovery and rival lab testing.
Department of Chemistry & Biochemistry, University of California, Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095 Article Views are the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results